Clinical Study Data Request Registered Users, Please Login

Find by:

Study ID:
Medicine:
Phase:

LUX Lung 2 Phase II Single Arm BIBW 2992 "Afatinib" in NSCLC With EGFR Activating Mutations
afatinib
1200.22
NCT00525148
Carcinoma, Non-Small-Cell Lung
Phase 2
 
November 2014

Powered by ideaPoint, Inc.